![Quiver Logo](/static/img/logo-icon.png)
![JSPRW logo](https://quiver-logos.s3.us-east-2.amazonaws.com/jsprw.png)
Japer Therapeutics, Inc. Warrants
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view JSPRW Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Recent trades of JSPRW by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by JSPRW's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Recent insights relating to JSPRW
Recent picks made for JSPRW stock on CNBC
ETFs with the largest estimated holdings in JSPRW
Flights by private jets registered to JSPRW
![Quiver Logo](/static/img/logo-icon.png)